eFFECTOR Therapeutics Inc. (EFTR) Records 1.36 million Shares Traded, Reaches $0.6300 High


After finishing at $0.61 in the prior trading day, eFFECTOR Therapeutics Inc. (NASDAQ: EFTR) closed at $0.52, down -15.41%. In other words, the price has decreased by -$0.0940 from its previous closing price. On the day, 1357174 shares were traded. EFTR stock price reached its highest trading level at $0.6300 during the session, while it also had its lowest trading level at $0.5133.

Do You Know The Best Place To Find Gains In Volatile Markets?

In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.

Click here for full details and to join for free


Our goal is to gain a better understanding of EFTR by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.10 and its Current Ratio is at 1.10. In the meantime, Its Debt-to-Equity ratio is 7.38 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stifel on January 25, 2022, Downgraded its rating to Hold and sets its target price to $6.20 from $20 previously.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 04 when Ehrlich Christopher B bought 346 shares for $0.57 per share. The transaction valued at 197 led to the insider holds 35,213 shares of the business.

Ehrlich Christopher B bought 18,867 shares of EFTR for $10,377 on Sep 26. The Director now owns 34,867 shares after completing the transaction at $0.55 per share.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EFTR now has a Market Capitalization of 37.68M and an Enterprise Value of 33.07M. For the stock, the TTM Price-to-Sale (P/S) ratio is 21.32 while its Price-to-Book (P/B) ratio in mrq is 10.32.

Stock Price History:

Over the past 52 weeks, EFTR has reached a high of $1.48, while it has fallen to a 52-week low of $0.34. The 50-Day Moving Average of the stock is 0.7155, while the 200-Day Moving Average is calculated to be 0.6003.

Shares Statistics:

The stock has traded on average 714.35K shares per day over the past 3-months and 435.11k shares per day over the last 10 days, according to various share statistics. A total of 61.77M shares are outstanding, with a floating share count of 58.36M. Insiders hold about 0.80% of the company’s shares, while institutions hold 58.30% stake in the company. Shares short for EFTR as of Aug 30, 2023 were 912.04k with a Short Ratio of 0.91M, compared to 1.09M on Jul 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 1.48% and a Short% of Float of 2.00%.

Earnings Estimates

Its stock is currently analyzed by Extreme Networks, Inc. different market analysts. The consensus estimate for the next quarter is $98.78, with high estimates of $12.39 and low estimates of $0.52.

Analysts are recommending an EPS of between $Financial Services and $Healthcare for the fiscal current year, implying an average EPS of $Utilities. EPS for the following year is $Stocks, with Stocks analysts recommending between $Stocks and $Stocks.


Please enter your comment!
Please enter your name here